The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

16 Jul 2008 07:00

RNS Number : 1560Z
Danka Business Systems PLC
16 July 2008
 



For Immediate Release

15 July 2008

Danka Business Systems PLC

("Danka" or the "Company")

Announcement of results for the quarter and year ended 31 March 2008

Danka Business Systems PLC has today filed with the U.S. Securities and Exchange Commission in its Annual Report on Form 10-K (the "Form 10-K") its financial results for the quarter and year ended 31 March 2008, prepared in accordance with US GAAP (the "US GAAP Results").

The release of the US GAAP Results as set forth in the Form 10-K for the year and quarter ended 31 March 2008 does not satisfy the Company's requirements under the Disclosure and Transparency Rules ("DTR"). The Company intends to publish its financial results for the year ended 31 March 2008, prepared in accordance with IFRS, in order to comply with DTR4.1 no later than 31 July 2008.

As set out in US GAAP Results, for the year ended 31 March 2008:

Net loss from continuing operations was $29.3 million in fiscal year 2008 compared to a net loss from continuing operations of $48.7 million in the year-ago period. The Company incurred a net loss from continuing operations available to common shareholders of $0.83 per American Depositary Share ("ADS") during the current period compared to net loss from continuing operations of $1.11 per ADS in the year-ago period. For the fiscal year 2008, the Company's revenue decreased by $32.0 million or 7.1% from fiscal year 2007 to $418.2 million with retail equipment, supplies and related sales declining $10.5 million or 5.3% to $189.6 million. Retail service revenue declined $19.0 million or 8.0% to $217.1 million and rental revenue was down $2.5 million or 17.8% to $11.5 million for fiscal year 2008. Total gross profit margin decreased to 33.9% during fiscal year 2008 from 34.6% in the year-ago period. Selling, general and administrative expenses ("SG&A") in the current year decreased by $15.7 million or 9.9% from the year-ago period to $143.8 million from $159.5 million. Operating loss from continuing operations was $4.3 million for fiscal year 2008 compared to a loss of $13.0 million in the prior year period. 

Total assets as of March 31, 2008 decreased $194.9 million or 46.7% from March 31, 2007 to $222.1 million. Total liabilities decreased $159.8 million from March 31, 2007, or 41.1% to $229.2 million.

The Company's net cash flow used in operating activities for continuing operations during fiscal year 2008 and 2007 was $29.8 million and $25.9 million respectively. Net cash flow used in investing activities from continuing operations during fiscal years 2008 and 2007 was $4.2 million and $11.2 million respectively. Net cash flow used in financing activities was $141.5 million for fiscal year 2008 while net cash flow provided by financing activities during fiscal year 2007 was $5.0 million.

On June 27, 2008, the Company completed the sale of its U.S. operating subsidiary, Danka Office Imaging Company ("DOIC"). Pursuant to a stock purchase agreement, the Company sold its U.S. operations to Konica Minolta Business Solutions U.S.A., Inc. ("Konica Minolta") in a sale of all the outstanding capital stock of DOIC for a purchase price of U.S. $240 million in cash, subject to an upward or downward adjustment of U.S. $10 million. The purchase price adjustment cannot exceed $10 million. In addition, the sum of $10 million was held back by Konica Minolta from the amount paid at closing as security for the Company's purchase price adjustment obligations. $25 million of the purchase price paid by Konica Minolta at closing will be held in escrow for a period of four years following closing to satisfy any and all claims by Konica Minolta which may be made under the stock purchase agreement. 

The Board of Directors of the Company is evaluating the alternatives available with respect to the net proceeds from the sale of DOIC to Konica Minolta - primarily how such proceeds may be distributed to Danka shareholders. There is no guarantee that any future alternative chosen by the board of directors will result in any return to holders of Danka's ordinary shares (including holders of ADSs). In addition, there is no guarantee that the holders of the Company's 6.50% senior convertible participating shares will not take action(s) available to them under applicable law, for example seeking a winding up of the Company, to recover amounts to which they are entitled pursuant to the Company's articles of association. Such amounts exceed the amount of the net proceeds from the sale of DOIC.

The US GAAP Results and Form 10-K are available in full on the SEC website: www.sec.gov and also on the Company's websitewww.dankabusinesssystemsplc.com.

Enquiries

Danka: Jean JohnsonGeneral Counsel, (727) 456-4460

Weber Shandwick Financial (London)

James Chandler/Laura Vaughn, 020 7067 0700

Evolution Securities Limited (London)

(Sponsor to Danka Business Systems PLC)

Stuart Andrews / Bobbie Hilliam, 020 7071 4300

Certain statements contained herein, or otherwise made by our officers, including statements related to our future performance and our outlook for our businesses and respective markets, projections, statements of our plans or objectives, forecasts of market trends and other matters, are forward-looking statements, and contain information relating to us that is based on our beliefs as well as assumptions, made by, and information currently available to us. The words "goal", "anticipate", "expect", "believe", "could", "should", "intend" and similar expressions as they relate to us are intended to identify forward-looking statements, although not all forward looking statements contain such identifying words. No assurance can be given that the results in any forward-looking statement will be achieved. For the forward-looking statements, we claim the protection of the safe harbor for forward-looking statements provided for in the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. Such statements reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially from those reflected in the forward-looking statements. Factors that might cause such actual results to differ materially from those reflected in any forward-looking statements include, but are not limited to, the following: (i) the evaluation of various alternatives following the sale of our remaining operations, including, without limitation, a members voluntary liquidation; (ii) any inability to successfully implement such alternative(s); (iii) any material adverse change in financial markets, the economy or in our financial position; (iv) any inability to record and process key data due to ineffective implementation of business processes and policies; (v) any negative impact from the loss of any of our senior or key management personnel; (vi) any incurrence of tax or other liabilities or tax or other payments beyond our current expectations, which could adversely affect our liquidity; (vii) any negative impact of the accreted value of our outstanding preferred stock or its continued accretion; (viii) any negative impact of our continued organization as an England and Wales registered Company following the sale of our U.S. operating business; (ix) actions of governmental entities, including regulatory requirements; (x) actions by shareholders in connection with the distribution of the net proceeds from sale of Danka Office Imaging Company; (xi) the outcome of legal proceedings to which we are or may become a party; and (xii) other risks including those risks identified in any of our filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect our analysis only as of the date they are made. Except as required by applicable law, we undertake no obligation, and do not intend, to update these forward-looking statements to reflect events or circumstances that arise after the date they are made. Furthermore, as a matter of policy, we do not generally make any specific projections as to future earnings, nor do we endorse any projections regarding future performance, which may be made by others outside our Company.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR MGGMNMKFGRZZ
Date   Source Headline
10th Sep 20217:00 amRNSIssue of unlisted option & PDMR/PCA notifications
1st Sep 20217:02 amRNSTotal Voting Rights and Capital
1st Sep 20217:01 amRNSHalf-year Report
1st Sep 20217:00 amRNSChange to Board of Directors
11th Aug 20217:00 amRNSProposed Cancellation of London Listing
6th Aug 20217:56 amRNSIssue of Shares and Unlisted Options
2nd Aug 20217:00 amRNSTotal Voting Rights and Capital
30th Jul 20217:00 amRNSAmended Constitution
30th Jul 20217:00 amRNSResult of AGM
29th Jul 20217:00 amRNSQuarterly Activities Report and Appendix 5B
5th Jul 20217:00 amRNSCompany Presentation and Video
1st Jul 202111:06 amRNSNotice of AGM
1st Jul 20217:00 amRNSTotal Voting Rights
25th Jun 20219:31 amRNSNotification of PDMR transaction
25th Jun 20217:26 amRNSProposed issue of unlisted options
17th Jun 20217:00 amRNSColluli Project Update
11th Jun 20217:17 amRNSReport on Payments to Governments
1st Jun 20217:00 amRNSTotal Voting Rights and Capital
27th May 20217:00 amRNSColluli Project Update
21st May 20217:52 amRNSAppendix 3Y
21st May 20217:48 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSColluli Project - RO Plant Manufacturing Underway
12th May 20217:01 amRNSA$20.3M Placement Endorses Danakali's SOP Project
12th May 20217:00 amRNSCorrection of Announcement - Issue of Shares
6th May 20219:12 amRNSIssue of shares
6th May 20217:00 amRNSNotification of PDMR and PCA transactions
30th Apr 20219:53 amRNSAnnual Report to Shareholders
30th Apr 20217:00 amRNSQuarterly Activities Report and Appendix 5B
29th Apr 20217:05 amRNSCompany Presentation
29th Apr 20217:00 amRNSA$20.3M Placement to Advance Colluli
27th Apr 20217:00 amRNSASX Trading Halt and Proposed Fundraise
19th Apr 202110:15 amRNSAdviser Appointment
13th Apr 20217:00 amRNSResignation of CFO
6th Apr 20217:00 amRNSTotal Voting Rights and Capital
6th Apr 20217:00 amRNSCorrection to Corporate Presentation
31st Mar 20217:26 amRNSRelease of 2020 Financial Report
26th Mar 20217:00 amRNSExecutive Chairman remuneration
24th Mar 20219:31 amRNSIssue of unlisted options
24th Mar 20219:29 amRNSProposed issue of unlisted options
22nd Mar 20217:34 amRNSCompany Presentation
10th Mar 20217:00 amRNSClean energy zero carbon SOP
2nd Mar 20218:36 amRNSTotal Voting Rights and Capital
26th Feb 20217:00 amRNSAppointment of Executive Chairman and restructure
23rd Feb 20219:13 amRNSResponse to ASX price and volume query
15th Feb 20219:01 amRNSIssue of shares & options, PDMR/PCA transactions
11th Feb 20217:00 amRNSCompany Presentation
1st Feb 20217:53 amRNSTotal Voting Rights
29th Jan 20217:54 amRNSIssue of unlisted options
29th Jan 20217:50 amRNSProposed issue of securities
28th Jan 20217:37 amRNSQuarterly Report and Appendix 5B

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.